Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fruitomin is a parenteral nutrition therapy developed by Taj Pharma, formulated as an intravenous injection containing a balanced mixture of essential amino acids, vitamins, and fructose (fruit sugar). It is primarily indicated for patients requiring nutritional support due to an inability to ingest or absorb nutrients through the gastrointestinal tract, such as those recovering from major surgery, severe trauma, or chronic wasting diseases. The amino acids in the formulation provide the necessary building blocks for protein biosynthesis and the maintenance of a positive nitrogen balance. Fructose serves as an immediate carbohydrate energy source, while the included vitamins (typically B-complex and Vitamin C) act as vital cofactors for various metabolic and enzymatic pathways, supporting cellular repair and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fruitomin.